The OTC derivative reform debate has clearly moved from one over market structure to one over politics. Whether one is a Republican or Democrat
should have nothing to do with determining the best market structure going forward – but I’m not so naive. From the story:
“Lincoln’s bill has made the situation much more contentious than it already was,” McPartland said in a telephone interview.